About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 843 record(s)
Req # A-2021-000663
Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: E2B_03293753.Organization: Health Canada
September 2023
Req # A-2022-001661
Adverse Drug Reaction (ADR). Report number: E2B_05716216.Organization: Health Canada
September 2023
Req # A-2023-000352
Adverse Drug Reaction (ADR) for LANREOTIDE. Report number: E2B_05322380.Organization: Health Canada
September 2023
Req # A-2023-000381
Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_03009425, E2B_01335934, E2B_02096585, E2B_01892634, E2B_02393844, E2B_02387551, E2B_02826826, E2B_02867073, E2B_02455143, E2B_03044908.Organization: Health Canada
September 2023
Req # A-2023-000416
Adverse Drug Reaction (ADR). Report number: 000630138.Organization: Health Canada
September 2023
Req # A-2023-000468
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103496-815, Investing in Canada Plan.Organization: Health Canada
September 2023
Req # A-2023-000529
Adverse Drug Reaction (ADR). Report number: E2B_02891245.Organization: Health Canada
September 2023
Req # A-2023-000548
Adverse Drug Reaction (ADR). Report number: E2B_06076856.Organization: Health Canada
September 2023
Req # A-2023-00632
I request information regarding the number of IAD cases, approvals and refusals for all IAD decision-makers in Western Canada for the past five years under both s.117(1)(b) and s. 4 of the IRPR, categorized as follows: · Broken down by Member, including Madame Anselm · Broken down by Hearing type and section of the Act/Regulations in the issue · Broken down by outcome, including: - Percentage of withdrawn appeals - Percentage of appeals granted - Percentage of appeals determined on joint recommendations. Timeframe: July 26th 2018 to July 26th 2023Organization: Immigration and Refugee Board of Canada
September 2023
Req # 1A-2023-08617
Requesting SPOUSAL WORK PERMIT DOCUMENTS with country-wise breakdown for time period - January 2019 till March 2023. 1. Total number of spousal work permit applications received from across the world 2. Out of the total spousal work permit applications, number of approved and rejected spousal work permits 3. Out of the total approved spousal work permit applications, total number of spousal work permits applied through an authorized representative 4. Out of the total approved spousal work permit applications, total number of spousal work permits applied through an unauthorized representative 5. Out of the total approved spousal work permit applications, total number of spousal work permits applied through no representative 6. Out of the total rejected/refused spousal work permit applications, total number of spousal work permits applied through an authorized representative 7. Out of the total rejected/refused spousal work permit applications, total number of spousal work permits applied through an unauthorized representative 8. Out of the total rejected/refused spousal work permit applications, total number of spousal work permits applied through no representativeOrganization: Immigration, Refugees and Citizenship Canada
September 2023